Barely Significant
← all excerpts

Desmocollin-3 Is a Novel Target Receptor for Targeted Drug Delivery for Malignant Prostate Cancer.

Pharmaceutics · 2026 · PMC13415596 · PMID 42514882

Europe PMCDOI
1
hedged sentence
0.0001
closest p · 0.0× alpha
0.0001
boldest claim

The sentences

highly significantp < 0.0001actually significant
Statistical analysis confirmed a highly significant efficacy of Pr10-MMAE treatment compared to both the control and free-MMAE-treated groups ( p < 0.0001). 3.3.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.